## Interpretation of Hepatitis B Serology ### Clinical Context This patient presents with acute hepatitis (markedly elevated transaminases, jaundice, hepatomegaly) with a clear temporal relationship to a needle-stick injury 8 weeks prior, placing him in the acute phase of HBV infection. ### Serological Marker Analysis | Marker | Result | Interpretation | |--------|--------|----------------| | **HBsAg** | Positive | Indicates active HBV infection (acute or chronic) | | **Anti-HBc IgM** | Positive | **Hallmark of acute HBV infection** — appears early, peaks at 4–6 weeks, persists 6 months | | **Anti-HBc total** | Positive | Indicates past or current HBV exposure | | **HBeAg** | Positive | Indicates high viral replication and infectivity | | **Anti-HBe** | Negative | Confirms active viral replication phase | | **Anti-HBs** | Negative | Immunity has not yet developed | ### Key Point: **Anti-HBc IgM is the single most reliable marker to distinguish acute from chronic hepatitis B.** Its presence in this clinical context (acute hepatitis symptoms, recent exposure, high transaminases) definitively indicates acute infection. ### High-Yield: The **window period** (HBsAg negative, anti-HBc positive, anti-HBs negative) may occur during early acute infection or late chronic infection, but anti-HBc IgM will be positive only in acute HBV. ### Clinical Pearl: In acute hepatitis B, HBsAg typically becomes undetectable within 6 months as the patient either clears the virus (developing anti-HBs) or progresses to chronicity (HBsAg persists beyond 6 months). This patient is in the acute phase with ongoing viral replication (HBeAg+, HBV DNA high). ### Mnemonic: **"IgM = Immediate (acute)"** — Anti-HBc IgM appears early in acute HBV and is your diagnostic anchor for distinguishing acute from chronic disease.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.